Market Overview

BMO Capital Upgrades Halozyme Therapeutics, Inc. to Outperform, Raises to $12.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS

Latest Ratings for HALO

DateFirmActionFromTo
Aug 2015JMP SecuritiesMaintainsMarket Outperform
Jun 2015JMP SecuritiesMaintainsMarket Outperform
Mar 2015BMO CapitalMaintainsOutperform

View More Analyst Ratings for HALO
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (HALO)

Get Benzinga's Newsletters